科學+家 心脑血管研究 200g Vascular Study

SKU Scientist Home 401
HK$390.00
In stock
1
Product Details

心血管疾病分子機制的新認識

脂肪酸膠束和囊泡形成過程及其在人體內的生理表現。這一過程有助於瞭解動脈鈣化,為什麼冠狀動脈、主動脈和頸動脈是受影響最大的血管,以及切應力較低的內皮區域斑塊的優先分佈。系統緩衝液在控制血液pH值中的作用,以及重金屬、飲食和乙醇攝入等污染物對心血管疾病的影響。最重要的心血管危險因素是根據其對降低血液pH值或新增血液FFA濃度的影響、或兩者兼而有之。心血管風險保護因素也找到了一個解釋內提出的框架。最後,在製定預防心血管疾病的策略時,強調瞭解血液pH值、游離脂肪酸濃度和血液中白蛋白濃度的重要性。

Ref: https://www.discoverymedicine.com/Antonio-H-Reis/2...

科學+家 心腦血管研究

適合關注:甘油三脂(1,2,15)、膽固醇(6,15)、血壓(5,7,8)、血流暢通(3,4,11)、心腦血管健康(9,10,14,15)、動脈血管彈性(12,13,15)

使用方法:每天早晚各一茶匙,加入250毫升開水攪拌,餐後飲用

注意:

・本產品為營養補充品,不能代替藥物

・如有不適,建議停止服用

・如不瞭解問題原因或問題持續,請儘快諮詢生

・孕婦、嬰幼兒慎用

重要提示:

如果出現以下情况,則不適合服用本補充劑:

  • 持續性頭暈、心絞痛、心口灼燒、極高血壓/低血壓、出血(請及時就醫)
  • 有無法解釋的血管問題(建議進行醫學檢查和治療)
  • 手術前後1周
  • 如果出現過敏或不良反應,停止服用

建議:

  • 試一個月。如無積極進展,建議停止服用並及時就醫。
  • 如果觀察到積極進展,您可以在3至12個月期間繼續並監測進展。
  • 在獲得滿意的結果後,可定期服用推薦劑量的一半,以進行維護。

可能的情況:

  • 膽固醇和血壓測試的數據是進展的良好參攷。
  • 建議每月定期檢查血壓和膽固醇水准。

溫馨提示:

  • 少吃油炸或烤的食物,保持清淡的飲食。
  • 逐步進行適量的有氧運動,增强心肺功能。
  • 多喝水(每天2000毫升)以促進新陳代謝。

儲存方法:請存放在陰涼乾燥處

規格型號:200克/粉劑/瓶裝

原產地:香港

主要成份:异麥芽酮糖,鼠尾草提取物,牛磺酸、桑葉提取物、非洲芒果提取物、洛神花提取物、檸檬酸、玉米提取物、維他命E、納豆激酶、輔酶Q10、槴子花提取物

Towards a New Understanding of the Molecular Mechanisms of Cardiovascular Disease

Fatty acid micelles and vesicles with an acidic core can develop, and the physiological manifestations of such process in the human body. The process allows the understanding of arterial calcification, why coronary arteries, aorta, and carotids are the most affected vessels, and the preferential distribution of plaques on the areas of the endothelium where shear stress is lower. The role of systemic buffers in the control of blood pH, and the effects of pollutants, namely heavy metals, diet, and ethanol intake, on cardiovascular risks. The most important cardiovascular risk factors are explained based on their effect on either lowering blood pH or increasing blood FFA concentration, or both. Cardiovascular risk protection factors also find an explanation within the proposed framework. As a final point, the importance of knowing blood pH and concentrations of free fatty acids and albumin concentrations in the blood is emphasized in developing a strategy of prevention of cardiovascular disease.

Scientist Home Vascular Study

Features

Triglyceride (1,2,15), Cholesterol (6,15), Blood pressure (5,7,8), Smooth blood flow (3,4,11), Cardiovascular and cerebrovascular health (9,10,14,15), Arterial elasticity (12,13,15)

Consumption

To be taken every morning and night after meal. Dissolve 1 teaspoon of powder in 250 ml of warm water.

Recommendation

  1. Try for 2 months. If there is no positive progress, suggest to stop taking and seek medical advice promptly.
  2. If positive progress is observed, you may continue and monitor the progress between 3 and 12 months.
  3. Upon attaining satisfactory results, may take half of the recommended dosage regularly for maintenance purposes.

Possible Outcome

  1. Data from cholesterol and blood pressure tests are good references on progress.
  2. Suggest to check blood pressure level regularly and cholesterol levels on a monthly basis.

Gentle Reminder

  1. Eat less fried or roasted food, maintain a light diet.
  2. Involve an adequate amount of aerobic exercise step by step to strengthen cardiopulmonary function.
  3. Drink more water (2000 ml per day) to facilitate metabolism.

Important Note

  1. Not suitable to take this supplement if:
    • Enduring dizziness, angina, heart burn, hyper/hypotension, bleeding (please seek medical advice promptly).
    • Having unexplained vascular problems (medical examination and treatment is recommended).
    • 2 weeks before and after any surgery.
    • Pregnant
    • Infants and young children.
  2. For serious or complicated health condition, please seek doctor's advice before taking.
  3. To stop taking if allergic or adverse reactions occur.
  4. This product is a nutritional supplement, and not meant for replacing medication.
Ingredients: Isomaltulose, Sage Leaf Extract, Taurine, Mulberry Leaf Extract, African Mango Extract, Hibiscus Extract, Citric Acid, Vitamin E, Corn Extract, Nattokinase, CoQ10, Gardenia Extract.
Packaging: 200g per bottle.

參考報告 Refs:

  1. Kianbakht, S., Abasi, B., Perham, M. and HashemDabaghian, F. (2011). Antihyperlipidemic Effects of Salvia officinalis L. Leaf Extract in Patients with Hyperlipidemia: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Phytotherapy Research, 25(12), pp.1849-1853.
  2. Sá, C., Ramos, A., Azevedo, M., Lima, C., Fernandes-Ferreira, M. and Pereira-Wilson, C. (2009). Sage Tea Drinking Improves Lipid Profile and Antioxidant Defences in Humans. International Journal of Molecular Sciences, 10(9), pp.3937-3950.
  3. Sumi, H., Hamada, H., Nakanishi, K. and Hiratani, H. (1990). Enhancement of the fibrinolytic activity in plasma by oral administration of nattokinase. ActaHaematol, 84, pp.139-143.
  4. Suzuki, Y., Kondo, K., Ichise, H., Tsukamoto, Y., Urano, T. and Umemura, K. (2003). Dietary supplementation with fermented soybeans suppresses intimal thickening. Nutrition, 19(3), pp.261-264.
  5. KIM, J., GUM, S., PAIK, J., LIM, H., KIM, K., OGASAWARA, K., INOUE, K., PARK, S., JANG, Y. and LEE, J. (2008). Effects of Nattokinase on Blood Pressure: A Randomized, Controlled Trial. Hypertension Research, 31(8), pp.1583-1588.
  6. Gurrola-Díaz, C., García-López, P., Sánchez-Enríquez, S., Troyo-Sanromán, R., Andrade-González, I. and Gómez-Leyva, J. (2010). Effects of Hibiscus sabdariffa extract powder and preventive treatment (diet) on the lipid profiles of patients with metabolic syndrome (MeSy). Phytomedicine, 17(7), pp.500-505.
  7. Herrera-Arellano, A., Miranda-Sánchez, J., Ávila-Castro, P., Herrera-Álvarez, S., Jiménez-Ferrer, J., Zamilpa, A., Román-Ramos, R., Ponce-Monter, H. and Tortoriello, J. (2006). Clinical Effects Produced by a Standardized Herbal Medicinal Product of Hibiscus sabdariffa on Patients with Hypertension. A Randomized, Double-blind, Lisinopril-Controlled Clinical Trial. PlantaMedica, 73(01), pp.6-12.
  8. HajiFaraji, M. and HajiTarkhani, A. (1999). The effect of sour tea (Hibiscus sabdariffa) on essential hypertension. Journal of Ethnopharmacology, 65(3), pp.231-236.
  9. Yamori, Y., Taguchi, T., Hamada, A., Kunimasa, K., Mori, H. and Mori, M. (2010). Taurine in health and diseases: consistent evidence from experimental and epidemiological studies. Journal of Biomedical Science, 17(Suppl 1), p.S6.
  10. Wójcik, O., Koenig, K., Zeleniuch-Jacquotte, A., Costa, M. and Chen, Y. (2010). The potential protective effects of taurine on coronary heart disease. Atherosclerosis, 208(1), pp.19-25.
  11. Liu, M., Wallmon, A., Olsson-Mortlock, C., Wallin, R. and Saldeen, T. (2003). Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. Am J ClinNutr, 77, pp.700-6.
  12. Littarru, G. and Tiano, L. (2007). Bioenergetic and Antioxidant Properties of Coenzyme Q10: Recent Developments. Molecular Biotechnology, 37(1), pp.31-37.
  13. Kumar, A., Kaur, H., Devi, P. and Mohan, V. (2009). Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome. Pharmacology & Therapeutics, 124(3), pp.259-268.
  14. Pepe, S., Marasco, S., Haas, S., Sheeran, F., Krum, H. and Rosenfeldt, F. (2007). Coenzyme Q10 in cardiovascular disease. Mitochondrion, 7, pp.S154-S167.
  15. He, S., Qian, Z., Wen, N., Tang, F., Xu, G. and Zhou, C. (2007). Influence of Crocetin on experimental atherosclerosis in hyperlipidamic-diet quails. European Journal of Pharmacology, 554(2-3), pp.191-195.


This product is not registered under the Pharmacy and Poisons Ordinance or the Chinese Medicine Ordinance. Any claim made for it has not been subject to evaluation for such registration. This product is not intended to diagnose, treat or prevent any disease.

Save this product for later